human embryonic stem cell-derived hepatocytes (Geron)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman embryonic stem cell-derived hepatocytes (Geron)

Drug Alias NamehESC-derived hepatocytes (Geron)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hepatogenic potential stem cell therapy

Mechanisms of ActionHepatocyte stimulants

TargetsUpdating

Therapy Area/IndicationsLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGeron Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGeron Corp

Active IndicationsN/A

Inactive IndicationsLiver Diseases

Other Information

ATC CodeN/A